Winners in Stage II of the Venture Kick competition

Updated: Feb 28, 2025

Geneva, Switzerland, November 1, 2020 – Abologix has been named one of the winners of the Venture Kick stage II start up competition.

Geneva, Switzerland, December 23, 2024 – Abologix has been awarded 100,000 CHF by the KICK FUND to progress its advanced preclinical...

Geneva, Switzerland, November 23, 2023 – Abologix successfully completes the Innosuisse-funded program for the initial characterization...

Geneva, Switzerland, December 20, 2022 – Abologix nominates monoclonal antibody H225 (blocker of JAM-C, Junction Adhesion Molecule C) as...

Comments